V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 260008373 | 260005621 | 1.63 | 66.8 | Neo-adjuvant (N) | 2014-03-06 | 2014-03-07 | CARBOPLATIN + PACLITAXEL | N | N | 260027771 | RITUXIMAB |
| 260008374 | 260005622 | null | null | null | null | 2016-01-15 | CHOP - 21 days | null | null | 260027776 | RITUXIMAB |
| 260008375 | 260005622 | 1.82 | 65 | Curative (C) | 2016-04-29 | 2016-04-29 | Rituximab (Maintenance) | N | null | 260027776 | RITUXIMAB |
| 260008376 | 260005623 | 1.66 | 84.9 | Palliative (P) | 2013-04-14 | 2015-07-31 | Rituximab (Maintenance) | N | N | 260027778 | MPV |
| 260008377 | 260005623 | 1.7 | null | Disease modification (D) | 2014-04-09 | 2014-04-09 | Rituximab | 2 | N | 260027778 | GDP |
| 260008378 | 260005623 | 1.77 | 74 | Not known (9) | 2015-06-09 | 2015-06-25 | EP 1 2 or 3 day | N | N | 260027778 | CHLORAMBUCIL + RITUXIMAB |
| 260008379 | 260005624 | 1.53 | 60 | Palliative (P) | 2016-01-10 | 2016-01-22 | Rituximab | N | N | 260027787 | FEC |
| 260008380 | 260005625 | 1.67 | 60.8 | Disease modification (D) | 2015-01-06 | 2015-01-11 | Chlorambucil | 02 | N | 260027788 | NOT MATCHED |
| 260008381 | 260005626 | null | null | Disease modification (D) | 2018-07-08 | 2018-07-16 | Rituximab | N | N | 260027790 | RITUXIMAB |
| 260008382 | 260005627 | 1.7 | 99 | Palliative (P) | null | 2014-03-29 | Bendamustine +/- Prednisolone | Y | null | 260027791 | ABVD |
| 260008383 | 260005627 | 1.65 | null | Curative (C) | 2016-05-23 | 2016-10-10 | Gemcitabine weekly | N | N | 260027791 | CAPECITABINE + OXALIPLATIN |
| 260008384 | 260005628 | 1.68 | 79.5 | Radical (R) | 2015-01-12 | 2015-02-25 | ESHAP | N | N | 260027796 | RITUXIMAB |
| 260008385 | 260005628 | 1.75 | 60 | Disease modification (D) | 2015-09-01 | 2015-09-02 | CYCLO + RITUXIMAB + VINCRISTINE | 02 | N | 260027796 | CHLORAMBUCIL |
| 260008386 | 260005629 | 1.8 | 58.4 | Curative (C) | 2017-07-13 | 2017-07-13 | Rituximab | 2 | N | 260027805 | BENDAMUSTINE |
| 260008387 | 260011901 | 0 | 86.5 | Curative (C) | 2015-07-18 | 2015-07-19 | Rituximab | 02 | null | 260027809 | CHLORAMBUCIL + RITUXIMAB |
| 260008388 | 260005630 | 1.6 | 64 | Curative (C) | 2017-07-20 | 2017-08-01 | FCR Oral Lite | 02 | null | 260027810 | RITUXIMAB |
| 260008389 | 260005631 | null | null | Palliative (P) | 2016-04-17 | 2016-04-17 | FEC 60 or 75 | N | N | 260027812 | BENDAMUSTINE |
| 260008390 | 260005632 | 1.73 | null | Curative (C) | 2016-04-30 | 2016-04-30 | Rituximab | N | N | 260027813 | RITUXIMAB |
| 260008391 | 260005632 | 1.7 | null | Palliative (P) | null | 2016-07-03 | ABVD | N | N | 260027813 | CISPLATIN + ETOPOSIDE |
| 260008392 | 260005633 | null | 106.5 | Adjuvant (A) | 2017-12-11 | 2017-12-11 | Carboplatin + Etoposide iv&po | N | N | 260027816 | CISPLATIN + IFOSFAMIDE + VINBLASTINE |
| 260008393 | 260011903 | null | 137 | null | 2016-07-13 | 2016-07-13 | Rituximab (Maintenance) | N | null | 260027819 | RITUXIMAB |
| 260008394 | 260011903 | 1.59 | 75.3 | Curative (C) | 2013-10-24 | 2013-11-13 | Bendamustine +/- Prednisolone | 02 | Y | 260027819 | PMITCEBO-R |
| 260008395 | 260011903 | 1.7 | 77.1 | Palliative (P) | 2016-03-10 | 2016-05-02 | Rituximab | N | N | 260027819 | RITUXIMAB |
| 260008396 | 260011903 | 1.69 | null | Palliative (P) | 2013-10-18 | 2013-11-16 | Docetaxel 75mg/m2 (21 day) | 2 | N | 260027819 | BENDAMUSTINE |
| 260008397 | 260011903 | null | 84 | Disease modification (D) | 2016-06-05 | 2016-06-19 | Cisplatin 7 day | N | N | 260027819 | AML17 TRIAL |
| 260008398 | 260005634 | 1.85 | 81.6 | Curative (C) | 2016-11-12 | 2017-09-06 | Hydroxycarbamide | 2 | N | 260027829 | RITUXIMAB |
| 260008399 | 260005635 | 0 | 95.6 | Curative (C) | 2015-03-30 | 2015-03-31 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE | N | N | 260027832 | RITUXIMAB |
| 260008400 | 260005635 | 1.63 | null | Disease modification (D) | 2017-05-24 | 2017-05-24 | CYCLOPHOSPHAMIDE | 01 | N | 260027832 | RITUXIMAB |
| 260008401 | 260015516 | 1.8 | 67.5 | Curative (C) | 2015-07-21 | 2015-07-29 | EP 1 2 or 3 day | N | N | 260027836 | CISPLATIN + ETOPOSIDE |
| 260008402 | 260005636 | 1.57 | 166 | Curative (C) | 2016-10-18 | 2016-10-21 | Rituximab (SUBCUTANEOUS Maintenance) | 02 | N | 260027837 | METHOTREXATE INTRATHECAL |
| 260008403 | 260005636 | 1.58 | 75 | Palliative (P) | 2019-02-06 | 2019-02-07 | PACIFICO TRIAL | N | N | 260027837 | RITUXIMAB |
| 260008404 | 260005637 | 1.65 | 94.4 | Palliative (P) | 2017-02-14 | 2017-02-28 | PACIFICO TRIAL | 02 | N | 260027845 | NOT MATCHED |
| 260008405 | 260011906 | null | 65.5 | Curative (C) | 2014-01-16 | 2014-02-08 | Cisplatin + Radiotherapy | 02 | Y | 260027849 | DHAP - R |
| 260008406 | 260005638 | 1.65 | 55 | Curative (C) | 2012-04-25 | 2013-02-12 | CISPLATIN + RT | N | N | 260027850 | RITUXIMAB |
| 260008407 | 260005639 | 1.81 | 66 | Curative (C) | 2015-08-19 | 2015-09-10 | RITUXIMAB + VINCRISTINE | N | N | 260027852 | RITUXIMAB |
| 260008408 | 260005639 | 1.57 | 76 | Curative (C) | 2015-06-29 | 2015-07-16 | Rituximab | N | N | 260027852 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE |
| 260008409 | 260005640 | 1.53 | 61 | Disease modification (D) | null | 2016-08-16 | Rituximab | N | N | 260027857 | RITUXIMAB |
| 260008410 | 260005640 | null | null | null | 2016-07-30 | 2016-08-17 | EP | 99 | null | 260027857 | CARBOPLATIN + ETOPOSIDE |
| 260008411 | 260005640 | 1.53 | 59.8 | Curative (C) | 2013-09-04 | 2013-09-10 | Rituximab (Maintenance) | N | N | 260027857 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE |
| 260008412 | 260005641 | 1.76 | 77.3 | Palliative (P) | 2014-11-18 | 2014-12-03 | Rituximab | 02 | N | 260027864 | RITUXIMAB |
| 260008413 | 260005641 | null | 56 | Curative (C) | 2014-11-05 | 2014-11-13 | Rituximab | N | N | 260027864 | CHLORAMBUCIL |
| 260008414 | 260005642 | 1.85 | null | Curative (C) | 2015-06-16 | 2015-06-23 | EP 1 2 or 3 day | N | N | 260027869 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE |
| 260008415 | 260005643 | 1.72 | 50.5 | null | 2016-07-23 | 2016-07-24 | Rituximab (Maintenance) | N | null | 260027871 | CAPECITABINE |
| 260008416 | 260005644 | 1.68 | 94 | Curative (C) | 2016-02-03 | 2016-02-26 | CHLORAMBUCIL + RITUXIMAB | N | null | 260027872 | BENDAMUSTINE |
| 260008417 | 260005644 | 1.87 | 75.1 | Palliative (P) | 2013-03-15 | 2013-04-10 | Rituximab | 02 | Y | 260027872 | FCR |
| 260008418 | 260005645 | 1.72 | null | Curative (C) | 2016-08-10 | 2016-08-17 | Bendamustine +/- Prednisolone | 02 | N | 260027876 | RITUXIMAB |
| 260008419 | 260005645 | 1.75 | 107.4 | Curative (C) | 2016-04-26 | 2016-05-24 | PACIFICO TRIAL | N | N | 260027876 | RITUXIMAB |
| 260008420 | 260005646 | null | 88.95 | Disease modification (D) | 2013-07-14 | 2013-07-20 | BLEOMYCIN + CISPLATIN + ETOPOSIDE | 02 | N | 260027881 | DOXORUBICIN + IFOSFAMIDE |
| 260008421 | 260011912 | 1.65 | 75 | Curative (C) | 2016-03-29 | 2016-04-13 | Rituximab | N | Y | 260027882 | RITUXIMAB |
| 260008422 | 260011912 | 1.64 | 62 | Palliative (P) | 2014-08-04 | 2014-08-04 | FEC 60 or 75 | N | N | 260027882 | CETUXIMAB |